Cargando…
Validation of anti-aging drugs by treating age-related diseases
Humans die from age-related diseases, which are deadly manifestations of the aging process. In order to extend life span, an anti-aging drug must delay age-related diseases. All together age-related diseases are the best biomarker of aging. Once a drug is used for treatment of any one chronic diseas...
Autor principal: | Blagosklonny, Mikhail V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806014/ https://www.ncbi.nlm.nih.gov/pubmed/20157517 |
Ejemplares similares
-
Selective anti-cancer agents as anti-aging drugs
por: Blagosklonny, Mikhail V
Publicado: (2013) -
Koschei the immortal and anti-aging drugs
por: Blagosklonny, M V
Publicado: (2014) -
Anti-aging: senolytics or gerostatics (unconventional view)
por: Blagosklonny, Mikhail V.
Publicado: (2021) -
Rejuvenating immunity: “anti-aging drug today” eight years later
por: Blagosklonny, Mikhail V.
Publicado: (2015) -
Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions
por: Blagosklonny, Mikhail V.
Publicado: (2012)